April 27, 2024

• 

[THE INVESTOR] As of Jan. 13 01:10 P.M., Genic rose 1.85% from yesterday to 13,800 won (US$11.72). It fell 8.03% over the past month. Standard deviation for the one month period stood at 2.8%.

Compared with its industry competitors listed on KOSDAQ, the monthly earnings rate of Genic was at low level, and its volatility for the one month relatively expanded.

The monthly return-on-risk, indicating the return on investment with consideration for risk, was -2.8%. Compared with the rest of the KOSPI industry, the return-on-risk was lower than the industrial mean of 3.2%.

■ Earnings & Valuation

Genic (123330)
Earnings report for 3Q (July – Sept.) of 2016
Revenue: 211.4 T    Down 25.4% on-quarter, up 6.2% on-year
Operating income: 14.7 T    Down 63.2% on-quarter, up 166.4% on-year
Net income: 7.7 T    Up 28.5% on-quarter, up 60.6% on-year

Investor Groups (Over the past five trading days)
Institutions 84.08%, Foreigners 7.67%, Individuals 84.08%

*Other investor groups including corporations are considered as “individuals.”

By HeRo (hero@heraldcorp.com)

This article is produced by the algorithm developed by the artificial intelligence developer ThinkPool in collaboration with Herald Corp.